Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Plant Cell Lysis Buffer: Preserve Signaling
2026-09-30
Plant Cell Lysis Buffer for WB and IP supports native protein extraction while protecting phosphorylation-sensitive and interaction-dependent information. This guide links buffer chemistry to assay design using the MAPK10–KRT16–RNF213 study as a practical model for interpreting Western blotting and immunoprecipitation data.
-
Ruxolitinib Phosphate: Applied JAK/STAT Workflows
2026-09-30
Build reproducible JAK1/2 inhibition workflows for cytokine signaling, rheumatoid arthritis research, autoimmune disease models, and aggressive tumor studies. This guide connects practical dosing and troubleshooting with a mechanistic ATC study linking JAK/STAT pathway modulation to mitochondrial dynamics and programmed cell death.
-
HotStart 2X Green qPCR Master Mix: Applied Workflows
2026-09-29
HotStart™ 2X Green qPCR Master Mix combines antibody-mediated hot-start control with SYBR Green detection for practical, scalable qPCR. Its workflow is especially useful for non-invasive genotyping, real-time PCR gene expression analysis, nucleic acid quantification, and RNA-seq validation when specificity and melt-curve confirmation matter.
-
AP20187: A Causal Framework for CID Assays
2026-09-29
AP20187 is a chemical inducer of dimerization that enables conditional control of engineered signaling proteins. This guide provides a distinct, evidence-aware framework for separating direct fusion-protein activation from downstream effects in metabolic, hematopoietic, and gene-regulation assays.
-
4-PBA: From ER Stress Control to Translational Insight
2026-09-28
4-Phenylbutyric acid is more than a routine ER-stress reagent: used as a rescue intervention, it can help researchers test whether proteostasis disruption is causally linked to autophagic cell death. This article translates recent liver-cancer evidence into a practical framework for study design, mechanistic validation, and translational decision-making.
-
PFOS Injury in HK-2 Cells: Ferroptosis and ER Stress
2026-09-28
A study of human proximal tubular epithelial cells links PFOS exposure with ferroptosis-associated biochemical changes and increased endoplasmic reticulum stress markers. The findings provide a cellular framework for investigating kidney toxicity, while leaving the causal relationship between these pathways and their relevance in vivo to be tested.
-
RRP Restores Lipid Balance in Hepatic I/R Injury
2026-09-27
This study links Radix Rehmanniae Praeparata (RRP) protection against hepatic ischemia/reperfusion injury to coordinated changes in cholesterol synthesis and efflux. In mice and fatty-acid-loaded hepatocytes, the extract engaged AMPK-associated signaling, constrained SCAP–SREBP2 processing, and supported LXRα-dependent cholesterol export.
-
JC-1 in Cancer Drug-Delivery Assays
2026-09-26
JC-1 can add a mitochondrial-function readout to studies of cancer drug delivery, but its signal should not be mistaken for a direct measure of cell death. This article connects the probe’s ratiometric behavior to a palbociclib nanocrystal-gel study and explains how to interpret the two kinds of evidence together.
-
AMPK–p62 Feedback Amplifies Stress Defense
2026-09-25
A 2024 study identifies a double-positive feedback loop between AMPK and SQSTM1/p62 that coordinates metabolic adaptation with NRF2-dependent antioxidant defense. Its mechanistic findings connect lysosomal stress, KEAP1 turnover, and AMPK activation, offering a framework for interpreting stress adaptation in cancer cells without establishing a clinical treatment strategy.
-
D-N-Acetylgalactosamine: Practical Workflow Guide
2026-09-25
D-N-Acetylgalactosamine (SKU B7904) is a defined amino sugar for workflows examining glycoprotein composition and brain heteropolysaccharides. Its reported water and DMSO solubility can support compatible aqueous preparations, but it is unsuitable for ethanol-based methods, and prepared solutions are not recommended for long-term storage.
-
PPM-18 in Redox and Inflammation Assay Design
2026-09-24
PPM-18 offers a way to investigate NF-κB-dependent iNOS expression without confusing it with other sources of reactive oxygen species. This article connects its established inflammatory mechanism to cardiac redox research and explains how to design assays that keep those pathways distinct.
-
Coelenterazine Workflows for ROS Assays
2026-09-24
Build more interpretable ROS and reporter assays with Coelenterazine by separating substrate chemistry from biological reporter activity. This practical guide covers solvent handling, controls, optimization, and how lessons from brain–kidney signaling research can sharpen experimental design without implying the reference study used this substrate.
-
Substance P: From Receptor Biology to Rigor
2026-09-23
Substance P research can move beyond a simple agonist-versus-control comparison. This article connects NK-1 receptor biology with matrix-aware assay design, explains what spectral-interference research can—and cannot—contribute, and offers practical guidance for translational studies.
-
AP20187 Workflows for Controlled Cell Signaling
2026-09-23
AP20187 is a chemical inducer of dimerization that converts engineered fusion proteins into tunable signaling switches for cell, metabolic, and gene-therapy research. This practical guide connects its conditional activation workflow with macrophage-driven nociceptor priming models, emphasizing controls, optimization, and limits of cross-domain translation.
-
MK 0893: Allosteric GCGR Assay Logic
2026-09-22
MK 0893 is a glucagon receptor antagonist that links allosteric receptor pharmacology with translational diabetes models. This guide shows how structural evidence, cAMP assays, selectivity controls, and in vivo glucose data can be integrated into a stronger type 2 diabetes research workflow.